COVID-19
Biosimilars
Cataract Therapeutics
DME
Gene Therapy
Workplace
Ptosis
Optic Relief
Imaging
Geographic Atrophy
AMD
Presbyopia
Ocular Surface Disease
Practice Management
Pediatrics
Surgery
Therapeutics
Optometry
Retina
Cataract
Pharmacy
IOL
Dry Eye
Understanding Antibiotic Resistance
Refractive
Cornea
Glaucoma
OCT
Ocular Allergy
Clinical Diagnosis
Technology

Fluorescein angiography indicated in patients with AIDS

June 1, 2002

Article

Editor's Note: In the absence of other identifiable causes, vision loss in HIV patients may be due to ischemic maculopathy, and that diagnosis should be investigated with fluorescein angiography. The clinical and angiographic features of five patients with HIV infection-related ischemic maculopathy were described in a paper recently published by Emmett T. Cunningham Jr., MD, PhD, MPH, and associates in the American Journal of Ophthalmology. In this new Ophthalmology Times column, Dr. Cunningham reviews the characteristic features of those patients and highlights the importance of considering a fluorescein angiogram in the diagnostic evaluation of HIV-positive patients with unexplained vision loss.